Advancing Evidence-Based Care in Diabetes and CKD
#ISNWCN π²πΎ #Nephpearls
π kdigo.org/wp-content/uplβ¦
Holistic approach for improving outcomes in patients with Diabetes and CKD
#ISNWCN π²πΎ #Nephpearls
Glucose-lowering agents in Type 2 Diabetes (T2D) and CKD: Indications and dose adjustments
#ISNWCN π²πΎ #Nephpearls
Mitigation strategies vs side effects of SGLT2inhibitors and GLP-1 Receptor agonists
#ISNWCN π²πΎ #Nephpearls
More on SGLT2 inhibitors:
π Expanded indications
π Initiation
π Dosing recommendations
#ISNWCN π²πΎ #Nephpearls
FIDELITY: Both CV and kidney benefits were consistent irrespective of SGLT-2i use at baseline
FIDELIO-DKD nejm.org/doi/full/10.10β¦
FIGARO-DKD nejm.org/doi/full/10.10β¦
FIDELITY academic.oup.com/eurheartj/artiβ¦
#VisualAbstract by @whatsthegfr
#ISNWCN π²πΎ #Nephpearls
DE BOER: New recommendation for non-steroidal MRA
#ISNWCN π²πΎ #Nephpearls
Potassium management with Finerenone
#ISNWCN π²πΎ #Nephpearls
CHAN: Dietary management in patients with T2D and CKD - 10 Tips to cut salt π§
#ISNWCN π²πΎ #Nephpearls
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.